Holding(s) in Company
08 Outubro 2003 - 11:55AM
UK Regulatory
RNS Number:6723Q
ReGen Therapeutics PLC
08 October 2003
ReGen Therapeutics Plc
8 October 2003
SUBSTANTIAL SHAREHOLDING
ReGen Therapeutics Plc (the "Company") announces that on 8 October 2003 it
received notification from Mr P. Garrod that he is beneficially interested in
24,000,000 ordinary shares of the Company representing 10.69% of the current
issued share capital of the Company.
For further information, please contact:
Andrew Marshall
Marshall Robinson Roe
Tel. 020 7960 6007
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLEALEPESLDFFE